OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Chimerix Inc/  US16934W1062  /

NASDAQ
2024-05-17  5:33:49 PM Chg. +0.0002 Volume Bid5:38:33 PM Ask5:38:33 PM High Low
0.9700USD +0.02% 16,161
Turnover: 13,254.7078		 0.9603Bid Size: 400 0.9700Ask Size: 1,000 0.9997 0.9500
GlobeNewswire 05-01 Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire 04-24 Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, ...
GlobeNewswire 04-16 Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 03-21 Chimerix Appoints Marc D. Kozin to Board of Directors
GlobeNewswire 02-29 Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
GlobeNewswire 02-22 Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Upd...
GlobeNewswire 02-06 atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
GlobeNewswire 2023-12-29 Chimerix Appoints Lisa Decker to Board of Directors
GlobeNewswire 2023-12-04 Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
GlobeNewswire 2023-11-24 Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-11-16 Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating an...
GlobeNewswire 2023-11-02 Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
GlobeNewswire 2023-10-26 Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on Novembe...
GlobeNewswire 2023-09-05 Chimerix to Participate in Upcoming Investor Conferences
GlobeNewswire 2023-08-16 Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC20...
GlobeNewswire 2023-08-16 Teknova Announces New Board Member, Martha J. Demski
GlobeNewswire 2022-03-21 Chimerix to Present at Maxim Group 2022 Virtual Growth Conference
GlobeNewswire 2022-03-01 Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
GlobeNewswire 2022-02-28 Chimerix to Present at Cowen and Company 42nd Annual Health Care Conference
GlobeNewswire 2022-02-24 Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiative (READDI) ...
GlobeNewswire 2022-02-22 Chimerix to Report Fourth Quarter and Year End 2021 Financial Results and Provide an Operational Upd...
GlobeNewswire 2022-01-20 Chimerix to Present at B. Riley Virtual Oncology Conference
GlobeNewswire 2022-01-03 Chimerix to Present at Virtual H.C. Wainwright BioConnect 2022 Conference
GlobeNewswire 2021-12-11 Annual Changes to the Nasdaq Biotechnology Index
GlobeNewswire 2021-11-19 Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Pre...